Episode 185: John Maraganore on his next act, plus Moderna's setback & the drug pricing reform saga
Nov 4, 2021
28:22
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
STAT's Rachel Cohrs drops in to talk about the latest updates in drug pricing reform. Then, John Maraganore joins us to talk about his decision to step down as CEO of Alnylam Pharmaceuticals after almost 20 years with the company. We also discuss the latest news in biotech, including the Covid-19 vaccine for kids and Moderna's disappointing earnings call.
The Readout Loud